Related Experiment Video
Updated: Jul 12, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
Published on: August 12, 2010
Restriction Checkpoint Controls Bradyzoite Development in Toxoplasma gondii
Anatoli V Naumov1, Chengqi Wang2, Dale Chaput3
1Department of Internal Medicine, Division of Infectious Diseases and International Medicine, Morsani College of Medicine, University of South Floridagrid.170693.a, Tampa, Florida, USA.
Researchers discovered a cell cycle switch in Toxoplasma gondii, controlled by atypical cyclins, that regulates the transition between rapid growth and chronic infection stages. This finding offers new drug targets against this human pathogen.
Area of Science:
- Parasitology
- Cell Biology
- Molecular Biology
Background:
- Toxoplasma gondii causes human toxoplasmosis, with tachyzoites driving acute disease and bradyzoites causing chronic infections.
- Understanding the parasite's cell cycle control is crucial for developing new therapies against chronic and drug-resistant stages.
Purpose of the Study:
- To identify the cell cycle mechanism regulating the switch between Toxoplasma gondii growth and differentiation.
- To characterize the roles of specific cyclins in parasite development and replication.
Main Methods:
- Investigated the G1 restriction checkpoint (R-point) in T. gondii.
- Utilized conditional knockdown models and gene expression analyses.
- Examined cyclin-TgCycP1, TgCycP2, and TgCyc5 interactions with TgCrk2 kinase.
Main Results:
- Identified a T. gondii R-point network involving TgCrk2 kinase and atypical cyclins (TgCycP1, TgCycP2, TgCyc5).
- TgCycP1 promotes rapid RH tachyzoite growth and inhibits differentiation.
- TgCycP2 regulates G1 duration in ME49 tachyzoites and bradyzoite replication; TgCyc5 is vital for tissue cyst maturation.
Conclusions:
- The T. gondii R-point network, composed of TgCrk2 and atypical cyclins, controls parasite growth and differentiation.
- TgCycP1, TgCycP2, and TgCyc5 have distinct roles in parasite development.
- This parasite-specific network presents potential drug targets for treating toxoplasmosis.
More Related Videos
09:52Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
Published on: July 12, 2013
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015